Sunesis Pharmaceuticals appoints William Quinn as CFO
December 1, 2017, San Francisco, Ca., USA - Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company, announced the appointment of William Quinn as chief financial officer and senior vice president, finance and corporate development.From 2003 to 2011, Mr. Quinn held various management positions at Jazz Pharmaceuticals, helping the company grow from a four-person startup to a successful commercial specialty pharmaceutical company.
Mr. Quinn began his career in the life science industry at Novation Biosciences.
He also has prior investing experience from his time as an Associate Partner at Mobius Venture Capital.
Mr. Quinn obtained his MBA from the Stanford Graduate School of Business and also earned an MA and BA from Stanford University. ■
LATEST MOVES FROM California
- Twitter adds two to board
- Surgical Affiliates appoints Scott Flacks as chief operating officer
- Sangamo Therapeutics appoints Edward Rebar as senior vice president
- Banc of California promotes Jason Pendergist to executive vice president
- Phoenix American Financial Services appoints Robyn Holloway as vice president
